Editorial: TGF-β as a Key Regulator of NK and ILCs Development and Functions.
作者信息
Bottino Cristina, Walzer Thierry, Santoni Angela, Castriconi Roberta
机构信息
Laboratory of Clinical and Experimental Immunology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Giannina Gaslini, Genoa, Italy.
Department of Experimental Medicine, University of Genoa, Genoa, Italy.
出版信息
Front Immunol. 2021 Jan 19;11:631712. doi: 10.3389/fimmu.2020.631712. eCollection 2020.
Abstract
摘要
相似文献
1
Editorial: TGF-β as a Key Regulator of NK and ILCs Development and Functions.
Front Immunol. 2021 Jan 19;11:631712. doi: 10.3389/fimmu.2020.631712. eCollection 2020.
2
IL-2/IL-18 prevent the down-modulation of NKG2D by TGF-beta in NK cells via the c-Jun N-terminal kinase (JNK) pathway.
Cell Immunol. 2006 Jul;242(1):39-45. doi: 10.1016/j.cellimm.2006.09.002. Epub 2006 Oct 27.
3
Canonical TGF-β Signaling Pathway Represses Human NK Cell Metabolism.
J Immunol. 2018 Jun 15;200(12):3934-3941. doi: 10.4049/jimmunol.1701461. Epub 2018 May 2.
4
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.
Sci Signal. 2016 Feb 16;9(415):ra19. doi: 10.1126/scisignal.aad1884.
5
A comparative study of the effects of inhibitory cytokines on human natural killer cells and the mechanistic features of transforming growth factor-beta.
Cell Immunol. 2014 Jul;290(1):52-61. doi: 10.1016/j.cellimm.2014.05.001. Epub 2014 May 13.
6
RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.
Cancer Res. 2004 Oct 15;64(20):7596-603. doi: 10.1158/0008-5472.CAN-04-1627.
7
Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
Cancer Res. 2009 Oct 1;69(19):7775-83. doi: 10.1158/0008-5472.CAN-09-2123. Epub 2009 Sep 8.
8
TGF-β-inducible microRNA-183 silences tumor-associated natural killer cells.
Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4203-8. doi: 10.1073/pnas.1319269111. Epub 2014 Feb 28.
9
Liver-Derived TGF-β Maintains the EomesTbet Phenotype of Liver Resident Natural Killer Cells.
Front Immunol. 2019 Jul 3;10:1502. doi: 10.3389/fimmu.2019.01502. eCollection 2019.
10
Transforming Growth Factor-β Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary Glands.
Immunity. 2016 May 17;44(5):1127-39. doi: 10.1016/j.immuni.2016.03.007. Epub 2016 May 3.
引用本文的文献
1
Reversing NK cell exhaustion: a novel strategy combining immune checkpoint blockade with drug sensitivity enhancement in the treatment of hepatocellular carcinoma.
Front Oncol. 2025 Jan 21;14:1502270. doi: 10.3389/fonc.2024.1502270. eCollection 2024.
2
Reconstitution of Natural Killer cells after allogeneic hematopoietic stem cell transplantation is facilitated by Huiyang-Guben decoction through activating the Smad7/Stat3 signal pathway.
Mol Cell Biochem. 2024 Jul;479(7):1721-1733. doi: 10.1007/s11010-023-04882-1. Epub 2023 Nov 16.
3
B7-H3 in Pediatric Tumors: Far beyond Neuroblastoma.
Cancers (Basel). 2023 Jun 21;15(13):3279. doi: 10.3390/cancers15133279.
本文引用的文献
1
NKG2D Ligand Shedding in Response to Stress: Role of ADAM10.
Front Immunol. 2020 Mar 25;11:447. doi: 10.3389/fimmu.2020.00447. eCollection 2020.
2
Hitting More Birds with a Stone: Impact of TGF-β on ILC Activity in Cancer.
J Clin Med. 2020 Jan 5;9(1):143. doi: 10.3390/jcm9010143.
3
mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-β-induced collagen biosynthesis.
Sci Signal. 2019 May 21;12(582):eaav3048. doi: 10.1126/scisignal.aav3048.
4
Novel Immunoregulatory Functions of IL-18, an Accomplice of TGF-β1.
Cancers (Basel). 2019 Jan 11;11(1):75. doi: 10.3390/cancers11010075.
5
Canonical TGF-β Signaling Pathway Represses Human NK Cell Metabolism.
J Immunol. 2018 Jun 15;200(12):3934-3941. doi: 10.4049/jimmunol.1701461. Epub 2018 May 2.
6
Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β.
Sci Transl Med. 2018 Jan 17;10(424). doi: 10.1126/scitranslmed.aan5488.
7
TGF-β1 Downregulates the Expression of CXCR1 by Inducing miR-27a-5p in Primary Human NK Cells.
Front Immunol. 2017 Jul 25;8:868. doi: 10.3389/fimmu.2017.00868. eCollection 2017.
8
SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-β signaling.
Nat Immunol. 2017 Sep;18(9):995-1003. doi: 10.1038/ni.3809. Epub 2017 Jul 31.
9
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.
Nat Immunol. 2017 Sep;18(9):1004-1015. doi: 10.1038/ni.3800. Epub 2017 Jul 31.
10
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.
Sci Signal. 2016 Feb 16;9(415):ra19. doi: 10.1126/scisignal.aad1884.
Zotero 插件